Literature DB >> 8776591

Cloning and expression of the gene involved in Sanfilippo B syndrome (mucopolysaccharidosis III B).

B Weber1, L Blanch, P R Clements, H S Scott, J J Hopwood.   

Abstract

Sanfilippo B syndrome is caused by a deficiency of alpha-N-acetylglucosaminidase, a lysosomal enzyme involved in the degradation of heparan sulphate. Accumulation of the substrate in lysosomes results in degeneration of the central nervous system with progressive dementia often combined with hyperactivity and aggressive behaviour. In order to clone the deficient gene, we purified the enzyme from human placenta and obtained amino acid sequence information. Alignment of one of the CNBr generated internal peptides to sequence from the database revealed the chromosomal location of the gene in the 5' upstream flanking region of the gene for 17-beta-hydroxysteroid-dehydrogenase at 17q21.1. The available DNA sequence was used to clone the cDNA coding for alpha-N-acetylglucosaminidase and analyse its gene structure. The gene is fully contained in the 5' upstream flanking region of the gene for 17-beta-hydroxysteroid-dehydrogenase and interrupted by five introns. The cDNA clone has a length of 2575 bp and encodes a protein of 743 amino acids. Chinese hamster ovary cells transfected with the cDNA construct show alpha-N-acetylglucosaminidase activity about 17-fold over background. This will allow correction studies with NAG deficient Sanfilippo B cell lines and facilitate the development of enzyme replacement therapy for these patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8776591     DOI: 10.1093/hmg/5.6.771

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  27 in total

1.  Therapeutic efficacy of bone marrow transplant, intracranial AAV-mediated gene therapy, or both in the mouse model of MPS IIIB.

Authors:  Coy D Heldermon; Kevin K Ohlemiller; Erik D Herzog; Carole Vogler; Elizabeth Qin; David F Wozniak; Yun Tan; John L Orrock; Mark S Sands
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

2.  Molecular defects in Sanfilippo syndrome type B (mucopolysaccharidosis IIIB).

Authors:  C E Beesley; M Jackson; E P Young; A Vellodi; B G Winchester
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Genetic testing of Mucopolysaccharidoses disease using multiplex PCR- based panels of STR markers: in silico analysis of novel mutations.

Authors:  Mehdi Shafaat; Mehrdad Hashemi; Ahmad Majd; Maryam Abiri; Sirous Zeinali
Journal:  Metab Brain Dis       Date:  2019-06-24       Impact factor: 3.584

4.  Multiplex Tandem Mass Spectrometry Enzymatic Activity Assay for Newborn Screening of the Mucopolysaccharidoses and Type 2 Neuronal Ceroid Lipofuscinosis.

Authors:  Yang Liu; Fan Yi; Arun Babu Kumar; Naveen Kumar Chennamaneni; Xinying Hong; C Ronald Scott; Michael H Gelb; Frantisek Turecek
Journal:  Clin Chem       Date:  2017-04-20       Impact factor: 8.327

Review 5.  Adeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration.

Authors:  Adeline A Lau; Kim M Hemsley
Journal:  J Mol Med (Berl)       Date:  2017-06-29       Impact factor: 4.599

6.  Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase.

Authors:  H H Li; W H Yu; N Rozengurt; H Z Zhao; K M Lyons; S Anagnostaras; M S Fanselow; K Suzuki; M T Vanier; E F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

7.  MPS-IIIA mice acquire autistic behaviours with age.

Authors:  Adeline A Lau; Sarah J Tamang; Kim M Hemsley
Journal:  J Inherit Metab Dis       Date:  2018-03-08       Impact factor: 4.982

8.  Identification of a common mutation (R245H) in Sanfilippo A patients from The Netherlands.

Authors:  B Weber; J J van de Kamp; W J Kleijer; X H Guo; L Blanch; O P van Diggelen; R Wevers; B J Poorthuis; J J Hopwood
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

9.  Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype.

Authors:  Marlies J Valstar; Hennie T Bruggenwirth; Renske Olmer; Ron A Wevers; Frans W Verheijen; Ben J Poorthuis; Dicky J Halley; Frits A Wijburg
Journal:  J Inherit Metab Dis       Date:  2010-09-18       Impact factor: 4.982

10.  Identification of 12 novel mutations in the alpha-N-acetylglucosaminidase gene in 14 patients with Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB).

Authors:  C E Beesley; E P Young; A Vellodi; B G Winchester
Journal:  J Med Genet       Date:  1998-11       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.